Advertisement|Remove ads.

Advertisement|Remove ads.
Shares of Classover Holdings Inc. (KIDZ) gave up some of its pre-market gains to trade 12% on Friday, after the company announced a memorandum of understanding with robotics education company Walimaker to bring robotics and AI learning programs to the North American K-12 market, covering kindergarten through 12th grade.
The partnership will leverage Classover’s digital education platform, learning centers, and summer camp channels and Walimaker’s robotics programming curriculum and hands-on engineering systems, Classover said.
Walimaker’s robotics ecosystem includes robotics kits, coding curriculum, and interactive learning modules designed to build engineering and problem-solving skills. The company added that its programs are used in more than 600 learning centers and schools.
Advertisement|Remove ads.
Earlier this month, Classover terminated a $400 million equity purchase facility with Solana Strategic Holdings, ending its Solana-focused digital asset treasury strategy. The company said it would redirect investment toward artificial intelligence and robotics to support long-term growth and reduce potential share dilution.
Shortly after exiting the digital-asset strategy, the company announced a strategic collaboration with YuGuang AI, an education technology firm focused on AI-generated instructional content. The partnership is set to explore developing AI-driven curriculum solutions, including tools for content creation, instructional design, and video-based learning.
Separately, Classover also implemented a 1-for-50 reverse stock split of its Class A and Class B common shares on March 9. Following the split, outstanding Class A shares decreased to about 130,700 from over 6.5 million, while Class B shares fell to roughly 1.1 million from nearly 55 million.
Advertisement|Remove ads.
Retail sentiment on Stocktwits for KIDZ remained in the ‘bullish’ territory over the past 24 hours, amid ‘high’ message volumes.
One user sees resistance at $3.3. It is currently trading around $3.
Advertisement|Remove ads.
Read also: IBRX Stock Rises 3% Pre-Market: ImmunityBio Reports Breakthrough In NK Cell Therapy Production
For updates and corrections, email newsroom[at]stocktwits[dot]com.
Comments posted here will also appear on symbol pages.